Pedro Macedonio García López
University of Guadalajara
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Pedro Macedonio García López.
Biological Research | 2013
Belinda Vargas Guerrero; Pedro Macedonio García López; Ana Elizabeth González Santiago; José A Domínguez Rosales; Carmen Magdalena Gurrola Díaz
OBJECTIVE The high global incidence of type 2 diabetes has challenged researchers to establish animal models that resemble the chronic stage observed in type 2 diabetes patients. One such model is induced by neonatal streptozotocin (n-STZ) administration to rat pups at 0, 2, or 5 days after birth. In this study, we assessed lns-1 gene expression and tissue insulin levels as well as serum concentration of glucose and insulin, insulin resistance, and histological changes of the islets of Langerhans in n5-STZ rats after 20-weeks post-induction. METHODS Wistar rat pups were randomly distributed into a control group and a streptozotocin-induced group. Experimental induction involved a single intraperitoneal injection of streptozotocin (150 mg/kg) into neonates at five days after birth. RESULTS At 20 weeks post-induction, streptozotocin-induced rats exhibited increased serum glucose levels, reduced serum insulin levels, impaired glucose metabolism and insulin resistance compared to control rats. Histologically, streptozotocin-induced rats exhibited atrophic islets, vacuolization, and significantly fewer insulin-positive cells. lns-1 gene expression was significantly decreased in n5-STZ rats in comparison to the control group. CONCLUSION Our findings support that the n5-STZ model 20 weeks post-induction represents an appropriate experimental tool to study T2D and to evaluate novel therapeutic agents and targets that involve insulin gene expression and secretion, as well as complications caused by chronic diabetes.Objective: The high global incidence of type 2 diabetes has challenged researchers to establish animal models that resemble the chronic stage observed in type 2 diabetes patients. One such model is induced by neonatal streptozotocin (n-STZ) administration to rat pups at 0, 2, or 5 days after birth. In this study, we assessed Ins-1 gene expression and tissue insulin levels as well as serum concentration of glucose and insulin, insulin resistance, and histological changes of the islets of Langerhans in n5-STZ rats after 20-weeks post-induction. Methods: Wistar rat pups were randomly distributed into a control group and a streptozotocin-induced group. Experimental induction involved a single intraperitoneal injection of streptozotocin (150 mg/kg) into neonates at fi ve days after birth. Results: At 20 weeks post-induction, streptozotocin-induced rats exhibited increased serum glucose levels, reduced serum insulin levels, impaired glucose metabolism and insulin resistance compared to control rats. Histologically, streptozotocin-induced rats exhibited atrophic islets, vacuolization, and signifi cantly fewer insulin-positive cells. Ins-1 gene expression was signifi cantly decreased in n5-STZ rats in comparison to the control group. Conclusion: Our fi ndings support that the n5-STZ model 20 weeks post-induction represents an appropriate experimental tool to study T2D and to evaluate novel therapeutic agents and targets that involve insulin gene expression and secretion, as well as complications caused by chronic diabetes.
Journal of Food Quality | 2017
Antonio Hilario Lara-Rivera; Pedro García-Alamilla; Laura Mercedes Lagunes-Gálvez; Ramón Rodríguez Macías; Pedro Macedonio García López; Juan Francisco Zamora Natera
Protein isolates prepared by alkaline solubilization followed by isoelectric precipitation and freeze-drying from six varieties of Lupinus angustifolius (Haags Blaue, Sonate, Probor, Borlu, Boregine, and Boruta) grown in Mexico were evaluated for functional properties: nitrogen solubility, water-holding capacity (WHC), oil holding capacity (OHC), emulsion activity index (EAI), emulsion stability index (ESI), foaming capacity (FC), foam stability (FS), and gelling minimum concentration (GMC). The nitrogen solubility values, WHC, OHC, and FC did not show significant differences between the protein isolates. The solubility of the isolates was minimal at pH of 4.0 and 5.0 while the regions of maximum solubility were found at pH of 2.0 and 10.0. There were significant differences in EAI and ESI depending on the varieties used. The isolates of the Boregine and Borlu varieties showed the highest EAI with 29.3 and 28.3 m2 g−1, respectively, while the lowest index was recorded in the isolate obtained from the Sonate variety (24.6 m2 g−1). Like solubility, these indices also increased at both extremes of pH evaluated; both properties were minimal in the isoelectric pH range (4.0 to 5.0).
Experimental and Toxicologic Pathology | 2017
T. Meraz Medina; Jacinto Bañuelos Pineda; Carmen Gómez Rodiles; Salvador Jiménez Vallejo; Ricardo Solís Zamora; Pedro Macedonio García López
Sparteine is one of the most toxic quinolizidine alkaloids found in leguminous plants. Several studies have demonstrated that sparteine affects the nervous system, blocking the nervous ganglion, producing antimuscarinic effects, depressing the central nervous system and causing neuronal necrosis. However, there are no reports identifying the areas of the brain that are sensitive to the toxic effects of this alkaloid. 32 adult Wistar rats were on study, sixteen were implanted with an intracerebral stainless steel cannula and randomly assigned to a control or experimental group (n=8). Animals, control and experimental, received daily intraventricular (ICV) injections of a sparteine or a sterile water solution for five consecutive days. Additionally, two groups of animals (8 rats each) received daily intraperotineal injections (IP) of a sparteine or sterile water solution for five consecutive days. 72h after the last dose, the animals were sacrificed, their brains removed, fixed and embedded in paraffin to obtain 10μm tissue slices. Brain slices were stained with H&E and evaluated under a light microscope. The main brain structures sensitive to sparteine were the cerebral cortex (frontal, fronto-parietal and striate) olfactory and amygdaloid areas, the ventromedial hypothalamic nucleus, the Purkinje cells in the cerebellum, and the CA1, CA3 and dentate gyrus regions of the hippocampus. Administration of sparteine, via ICV or IP, caused neuronal necrosis in brain structures, mainly related with cholinergic pathways.
European Journal of Pharmacology | 2004
Pedro Macedonio García López; P. Garzón de la Mora; Waleria Wysocka; Bárbara Maiztegui; María E. Alzugaray; Héctor Del Zotto; María I. Borelli
European Journal of Pharmacology | 2007
Teresa Bobkiewicz-Kozłowska; Marzena Dworacka; Sebastian Kuczyński; Małgorzata Abramczyk; Renata Kolanoś; Waleria Wysocka; Pedro Macedonio García López
Interciencia | 2010
Ramón Rodríguez Macías; Ernesto G Alcantar González; Gilberto Íñiguez Covarrubias; Francisco Zamora Natera; Pedro Macedonio García López; Mario Alberto Ruiz López; Eduardo Salcedo Pérez
Revista mexicana de micología | 2005
Conrado Soto-Velazco; Juan Carlos Serratos; Mario Alberto Ruiz López; Pedro Macedonio García López
Interciencia | 2015
José María Herrera Velazco; Pedro Macedonio García López; Ramón Rodríguez Macías; María de Lourdes Isaac Virgen; Mario Alberto Ruiz López; Juan Francisco Zamora Natera
Revista Fitotecnia Mexicana | 2002
Francisco Zamora Natera; Maurilio Martínez Rodríguez; Mario Alberto Ruiz López; Pedro Macedonio García López
Legume Research | 2017
Juan Francisco Zamora Natera; Celene del Rio Obregón; Isidro Zapata Hernández Ramón Rodríguez Macías; Pedro Macedonio García López